CLINICAL_TRIALS
trial_result
· 2015-12-09
Clinical Trial Update: Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE) [Phase 3]
Summary
Phase 3 SCATE trial in sickle cell disease was terminated and results were posted in December 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Sickle Cell Anemia | Phase 3 | Status: TERMINATED | Results posted: 2015-12-09